Association of the pretreatment lung immune prognostic index with immune checkpoint inhibitor outcomes in patients with advanced hepatocellular carcinoma

Association of the pretreatment lung immune prognostic index with immune checkpoint inhibitor outcomes in patients with advanced hepatocellular carcinoma

Abstract Objective To evaluate whether the pretreatment Lung Immune Prognostic Index (LIPI) is associated with outcomes in advanced hepatocellular carcinoma (HCC) patients under ICI. Methods A two-center retrospective study of patients with HCC treated with immune checkpoint inhibitors (ICIs) betwee...

Full description

Bibliographic Details
Main Authors: Tao Sun, Yusheng Guo, Bo Sun, Lei Chen, Yanqiao Ren, Licheng Zhu, Lijie Zhang, Yiming Liu, Chuansheng Zheng
Format: Article
Language:English
Published: BMC 2023-07-01
Series:European Journal of Medical Research
Subjects:
Immune checkpoint inhibitor
Hepatocellular carcinoma
Biomarker
LIPI
dNLR
LDH
Online Access:https://doi.org/10.1186/s40001-023-01198-0

Internet

https://doi.org/10.1186/s40001-023-01198-0

Similar Items